Cargando…
How controlled were dyslipidemias in a year of pandemic?
Autores principales: | Silva, E.M.M., Marques, B., Cunha, C., Ferreira, R., Bello, C., Limbert, C., Azinheira, J., Duarte, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415866/ http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.511 |
Ejemplares similares
-
Three Cases of Intermittent Fever and How They Were Treated
por: Boger, C. M.
Publicado: (1894) -
Lipid-lowering agents for dyslipidemia in patients who were infected with HIV in Taoyuan, Taiwan
por: Cheng, Shu-Hsing, et al.
Publicado: (2014) -
One year later: How outcomes of hip fractures treated during the “first wave” of the COVID-19 pandemic were affected
por: Konda, Sanjit R., et al.
Publicado: (2023) -
How is the Metabolic Syndrome Related to the Dyslipidemia?
por: Blaton, Victor
Publicado: (2007) -
The COVID-19 pandemic – How many times were we warned before?
por: Mahroum, Naim, et al.
Publicado: (2022)